IQMD
Income statement / Annual
Last year (2022), Intelligent Medicine Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Intelligent Medicine Acquisition Corp.'s net income was $11.41 M.
See Intelligent Medicine Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
| General & Administrative Expenses |
$1.28 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.28 M
|
$0.00
|
| Other Expenses |
$0.00
|
$0.00
|
| Operating Expenses |
$1.28 M
|
$0.00
|
| Cost And Expenses |
$1.28 M
|
$0.00
|
| Interest Income |
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$236,558.00
|
| EBITDA |
-$14.54 M |
$0.00 |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$26.74 M
|
$0.00
|
| Income Before Tax |
$11.97 M
|
$0.00
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
$562,567.00
|
$0.00
|
| Net Income |
$11.41 M
|
$0.00
|
| Net Income Ratio |
0
|
0
|
| EPS |
2.2 |
0 |
| EPS Diluted |
2.2 |
0 |
| Weighted Average Shares Out |
$5.18 M
|
$25.88 M
|
| Weighted Average Shares Out Diluted |
$5.18 M
|
$25.88 M
|
| Link |
|
|
